677 Lower risk of cardiovascular (CV) events and death in men receiving ADT by gonadotropin releasing hormone (GnRH) antagonist, degarelix, compared with luteinising hormone-releasing (LHRH) agonists

✍ Scribed by Tombal, B.; Albertsen, P.; De La Taille, A.; Van Der Meulen, E.; Persson, B-E.; Olesen, T.K.; Nilsson, J.

• Book ID: 122402928
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 142 KB
• Volume: 12
• Category: Article
• ISSN: 1569-9056
• DOI: 10.1016/S1569-9056(13)61159-8